These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grünert A. Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153 [Abstract] [Full Text] [Related]
3. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Kohse KP, Feifel K, Mayer-Wehrstein R. Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377 [Abstract] [Full Text] [Related]
4. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Haug C, Metzele A, Steffgen J, Grünert A. Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909 [Abstract] [Full Text] [Related]
5. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y. Am J Nephrol; 2001 May; 21(2):112-9. PubMed ID: 11359018 [Abstract] [Full Text] [Related]
6. Plasma human brain natriuretic peptide in chronic renal failure. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666 [Abstract] [Full Text] [Related]
7. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida O, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Am J Kidney Dis; 1994 Sep; 24(3):461-72. PubMed ID: 8079971 [Abstract] [Full Text] [Related]
8. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Raine AE, Bock A, Muller FB, Erne P, Bolli P, Brunner F, Buhler FR. Nephrol Dial Transplant; 1989 Sep; 4(3):222-7. PubMed ID: 2524680 [Abstract] [Full Text] [Related]
9. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. Clerico A, Caprioli R, Del Ry S, Giannessi D. J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728 [Abstract] [Full Text] [Related]
10. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Leskinen H, Vuolteenaho O, Leppäluoto J, Ruskoaho H. Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578 [Abstract] [Full Text] [Related]
11. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996 [Abstract] [Full Text] [Related]
12. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Clin Sci (Lond); 1986 Aug; 71(2):157-60. PubMed ID: 2941209 [Abstract] [Full Text] [Related]
13. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Haug C, Metzele A, Kochs M, Hombach V, Grünert A. Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764 [Abstract] [Full Text] [Related]
14. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. Clerico A, Iervasi G, Del Chicca MG, Emdin M, Maffei S, Nannipieri M, Sabatino L, Forini F, Manfredi C, Donato L. J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213 [Abstract] [Full Text] [Related]
15. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. Tanaka T, Hasegawa K, Fujita M, Tamaki SI, Yamazato A, Kihara Y, Nohara R, Sasayama S. J Am Coll Cardiol; 1998 Feb; 31(2):399-403. PubMed ID: 9462585 [Abstract] [Full Text] [Related]
16. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Hunt PJ, Espiner EA, Richards AM, Yandle TG, Frampton C, Nicholls MG. Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942 [Abstract] [Full Text] [Related]
17. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG. J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831 [Abstract] [Full Text] [Related]